Kazuhiko Takehara
Kazuhiko Takehara publishes mostly in Pathology and Forensic Medicine, Dermatology and Epidemiology, on topics such as Systemic Sclerosis and Related Diseases, Inflammatory Myopathies and Dermatomyositis and Autoimmune Bullous Skin Diseases.
- World rank
- #510,714 of 7,710,434 ranked researchers
- Rank in Japan
- #5,275 of 383,136
- Works
- 543
- Citations
- 24k
- Citations per work
- 43.9
What does Kazuhiko Takehara research?
Kazuhiko Takehara's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (8%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences26849.4%
- Medicine26849.4%
- Everything else19435.7%
- Life Sciences8114.9%
- 1Pathology and Forensic Medicine24% of their works
- 2Dermatology9% of their works
- 3Epidemiology9% of their works
- 4Rheumatology8% of their works
- 5Molecular Biology8% of their works
- 6Immunology7% of their works
Research topics
- Systemic Sclerosis and Related Diseases
- Inflammatory Myopathies and Dermatomyositis
- Autoimmune Bullous Skin Diseases
- Dermatologic Treatments and Research
- Connective Tissue Growth Factor Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Urticaria and Related Conditions
- Eosinophilic Disorders and Syndromes
Which keywords describe Kazuhiko Takehara's research?
The keywords of their largest research topics: Autoantibodies, Treatment, Fibrosis, Immunosuppressive Therapy, TGF-ß Signaling, Pulmonary Involvement, Systemic Sclerosis and Interstitial Lung Disease.
- Fusion Genes
- Chronic Spontaneous Urticaria
- Idiopathic Pulmonary Fibrosis
- CCN Family
- Hypertrophic Scarring
- Pemphigoid
- Diagnosis
- Inflammatory Myopathies
- Interstitial Lung Disease
- Pulmonary Involvement
- Immunosuppressive Therapy
- Treatment
- Autoantibodies
- Fibrosis
- TGF-ß Signaling
- Systemic Sclerosis
- Dermatomyositis
- Autoimmune
- Wound Healing
- Rituximab
- Keloids
- Connective Tissue Growth Factor
- TGF-ß
- Urticaria
- Hypereosinophilic Syndrome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Autoantibodies4704 topics
- Treatment3722 topics
- Fibrosis3503 topics
- Immunosuppressive Therapy3272 topics
- TGF-ß Signaling3062 topics
- Pulmonary Involvement2621 topic
- Systemic Sclerosis2621 topic
- Interstitial Lung Disease1542 topics
- Dermatomyositis1101 topic
- Inflammatory Myopathies1101 topic
- Autoimmune982 topics
- Diagnosis982 topics
- Wound Healing942 topics
- Pemphigoid651 topic
- Rituximab651 topic
- Hypertrophic Scarring501 topic
- Keloids501 topic
- CCN Family441 topic
- Connective Tissue Growth Factor441 topic
- Idiopathic Pulmonary Fibrosis441 topic
- TGF-ß441 topic
- Chronic Spontaneous Urticaria331 topic
- Urticaria331 topic
- Fusion Genes321 topic
- Hypereosinophilic Syndrome321 topic
Where does Kazuhiko Takehara work?
Kazuhiko Takehara's main affiliation in the publication record is Kanazawa University, Japan.
How many publications and citations does Kazuhiko Takehara have?
OpenAlex counts 543 works and 23,820 citations for Kazuhiko Takehara, an h-index of 84, ranking #510,714 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kazuhiko Takehara. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.